Sodium Citrate w/v Anticoagulant
These highlights do not include all the information needed to use SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP safely and effectively. See full prescribing information for SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP. SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP Sterile FluidPolyolefin Bag Initial U.S. Approval: 1978
Approved
Approval ID
c9d0e9c8-379f-4895-b272-329efab575c4
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 21, 2020
Manufacturers
FDA
Terumo BCT, Ltd
DUNS: 233649834
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
TRISODIUM CITRATE DIHYDRATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code14537-883
Application NumberBA125608
Product Classification
M
Marketing Category
C73584
G
Generic Name
TRISODIUM CITRATE DIHYDRATE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 31, 2019
FDA Product Classification
INGREDIENTS (3)
Citric Acid monohydrateInactive
Code: 2968PHW8QP
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT
TRISODIUM CITRATE DIHYDRATEActive
Quantity: 4 g in 100 mL
Code: B22547B95K
Classification: ACTIM